Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Blood advances - 7(2023), 21 vom: 14. Nov., Seite 6767-6770 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fillmore, Nathanael R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 06.11.2023 Date Revised 29.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1182/bloodadvances.2023011063 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361454635 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361454635 | ||
| 003 | DE-627 | ||
| 005 | 20231226085155.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2023011063 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1204.xml |
| 035 | |a (DE-627)NLM361454635 | ||
| 035 | |a (NLM)37647600 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fillmore, Nathanael R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.11.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a La, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Julie Tsu-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Corrigan, June K |e verfasserin |4 aut | |
| 700 | 1 | |a Branch-Elliman, Westyn |e verfasserin |4 aut | |
| 700 | 1 | |a Monach, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Brophy, Mary T |e verfasserin |4 aut | |
| 700 | 1 | |a Do, Nhan V |e verfasserin |4 aut | |
| 700 | 1 | |a Munshi, Nikhil C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d 2016 |g 7(2023), 21 vom: 14. Nov., Seite 6767-6770 |w (DE-627)NLM268683263 |x 2473-9537 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2023 |g number:21 |g day:14 |g month:11 |g pages:6767-6770 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/bloodadvances.2023011063 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2023 |e 21 |b 14 |c 11 |h 6767-6770 | ||